chr17-82905981-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005993.5(TBCD):āc.1850T>Cā(p.Met617Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.438 in 1,607,640 control chromosomes in the GnomAD database, including 157,642 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_005993.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBCD | NM_005993.5 | c.1850T>C | p.Met617Thr | missense_variant | 20/39 | ENST00000355528.9 | NP_005984.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBCD | ENST00000355528.9 | c.1850T>C | p.Met617Thr | missense_variant | 20/39 | 1 | NM_005993.5 | ENSP00000347719 | P1 |
Frequencies
GnomAD3 genomes AF: 0.485 AC: 73650AN: 151994Hom.: 18812 Cov.: 34
GnomAD3 exomes AF: 0.438 AC: 107922AN: 246480Hom.: 24511 AF XY: 0.443 AC XY: 59237AN XY: 133698
GnomAD4 exome AF: 0.433 AC: 629770AN: 1455528Hom.: 138815 Cov.: 44 AF XY: 0.435 AC XY: 315065AN XY: 723978
GnomAD4 genome AF: 0.485 AC: 73705AN: 152112Hom.: 18827 Cov.: 34 AF XY: 0.482 AC XY: 35822AN XY: 74356
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 06, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at